Primary Hepatic Cancer

Anan H. Said, Kirti Shetty, Ying Li, Boris Blechacz, Ernest Hawk, Lopa Mishra

Producción científica: Chapter

4 Citas (Scopus)


Primary hepatic cancer or hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third leading cause of cancer mortality in the United States. It occurs commonly in the setting of cirrhosis and chronic liver disease, particularly viral hepatitis. Radiological studies are the primary modality utilized in the diagnosis of HCC, and serum markers as well as histology have additional roles. HCC is typically diagnosed at an advanced stage of disease, and the median survival time after diagnosis ranges between 6 and 20 months. However, if diagnosed at an early stage, patients suffering from HCC can receive effective curative options including surgical resection, tumor ablation, or liver transplantation. New insights into molecular pathways and targeted therapies carry significant promise for patients with HCC. This edition first published 2013

Idioma originalEnglish (US)
Título de la publicación alojadaHandbook of Gastrointestinal Cancer
EditorialJohn Wiley and Sons
Número de páginas21
ISBN (versión impresa)9780470656242
EstadoPublished - nov 15 2012
Publicado de forma externa

ASJC Scopus subject areas

  • General Medicine


Profundice en los temas de investigación de 'Primary Hepatic Cancer'. En conjunto forman una huella única.

Citar esto